Beyond Net Debt To E B I T D A from 2010 to 2026
| DOCKF Stock | USD 0.16 0.09 36.00% |
Net Debt To EBITDA | First Reported 2010-12-31 | Previous Quarter (0.12) | Current Value (0.11) | Quarterly Volatility 2.7658409 |
Check Beyond Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Beyond Medical's main balance sheet or income statement drivers, such as Discontinued Operations of 122.5 K, Interest Expense of 7.9 K or Interest Income of 6 K, as well as many indicators such as Price To Sales Ratio of 3.49, Dividend Yield of 0.0 or Days Sales Outstanding of 11.75. Beyond financial statements analysis is a perfect complement when working with Beyond Medical Valuation or Volatility modules.
Beyond | Net Debt To E B I T D A | Build AI portfolio with Beyond Stock |
Latest Beyond Medical's Net Debt To E B I T D A Growth Pattern
Below is the plot of the Net Debt To E B I T D A of Beyond Medical Technologies over the last few years. It is a leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company's net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). Beyond Medical's Net Debt To EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Beyond Medical's overall financial position and show how it may be relating to other accounts over time.
| Net Debt To E B I T D A | 10 Years Trend |
|
Net Debt To E B I T D A |
| Timeline |
Beyond Net Debt To E B I T D A Regression Statistics
| Arithmetic Mean | 1.12 | |
| Geometric Mean | 0.27 | |
| Coefficient Of Variation | 247.34 | |
| Mean Deviation | 1.37 | |
| Median | 0.47 | |
| Standard Deviation | 2.77 | |
| Sample Variance | 7.65 | |
| Range | 11.7 | |
| R-Value | (0.11) | |
| Mean Square Error | 8.07 | |
| R-Squared | 0.01 | |
| Significance | 0.68 | |
| Slope | (0.06) | |
| Total Sum of Squares | 122.40 |
Beyond Net Debt To E B I T D A History
About Beyond Medical Financial Statements
Beyond Medical stakeholders use historical fundamental indicators, such as Beyond Medical's Net Debt To E B I T D A, to determine how well the company is positioned to perform in the future. Although Beyond Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Beyond Medical's assets and liabilities are reflected in the revenues and expenses on Beyond Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Beyond Medical Technologies. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Debt To EBITDA | (0.12) | (0.11) |
Currently Active Assets on Macroaxis
When determining whether Beyond Medical Techn is a strong investment it is important to analyze Beyond Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Beyond Medical's future performance. For an informed investment choice regarding Beyond Stock, refer to the following important reports:Check out the analysis of Beyond Medical Correlation against competitors. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Industrial Machinery & Supplies & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beyond Medical. If investors know Beyond will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beyond Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.06) | Revenue Per Share | Quarterly Revenue Growth (0.92) | Return On Assets | Return On Equity |
The market value of Beyond Medical Techn is measured differently than its book value, which is the value of Beyond that is recorded on the company's balance sheet. Investors also form their own opinion of Beyond Medical's value that differs from its market value or its book value, called intrinsic value, which is Beyond Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beyond Medical's market value can be influenced by many factors that don't directly affect Beyond Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beyond Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Beyond Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beyond Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.